<code id='147EDE1A18'></code><style id='147EDE1A18'></style>
    • <acronym id='147EDE1A18'></acronym>
      <center id='147EDE1A18'><center id='147EDE1A18'><tfoot id='147EDE1A18'></tfoot></center><abbr id='147EDE1A18'><dir id='147EDE1A18'><tfoot id='147EDE1A18'></tfoot><noframes id='147EDE1A18'>

    • <optgroup id='147EDE1A18'><strike id='147EDE1A18'><sup id='147EDE1A18'></sup></strike><code id='147EDE1A18'></code></optgroup>
        1. <b id='147EDE1A18'><label id='147EDE1A18'><select id='147EDE1A18'><dt id='147EDE1A18'><span id='147EDE1A18'></span></dt></select></label></b><u id='147EDE1A18'></u>
          <i id='147EDE1A18'><strike id='147EDE1A18'><tt id='147EDE1A18'><pre id='147EDE1A18'></pre></tt></strike></i>

          focus

          focus

          author:focus    Page View:774
          the shape of a medical note connected by dots and lines — health tech coverage from STAT
          Adobe

          In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

          But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

          advertisement

          This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Lasker Awards 2023: Winners in biomedical research
          Lasker Awards 2023: Winners in biomedical research

          Thewinnersofthe2023LaskerAwardsdistinguishedthemselvesinareasincludingAI-enabledproteinmodeling.Wiki

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Medicare inequities exacerbate Puerto Rico’s health disparities

          RamonEspinosa/APWhenIaccompanymyfathertohisregularcardiologistappointmentinPuertoRico,worryandsadnes